Project Twenty21 is committed to scientific excellence and the development of independent scientific evidence. It is supported by a scientific oversight board, consisting of the following expertise:
Professor David Nutt DM, FRCP, FRCPSYCH, FSB, FMEDSCI. Professor of Neuropsychopharmacology at Imperial College London.
Professor Eileen Joyce MA, PhD, MB BChir, MRCP, FRCPsych Professor of Neuropsychiatry at The Institute of Neurology, University College London.
Professor Michael Lynskey BSc (Hons), MSc, PhD. Epidemiologist.
Professor Val Curran MA (Cantab) PhD D CLin Psy FRSB; Director UCL Clinical Psychopharmacology Unit.
Professor Adam Winstock MD MRCPsych MRCP FAChAM. Consultant Psychiatrist and Addiction Medicine Specialist.
Dr Alan Fayaz MD(Res) MRCP FRCA FFPMRCA. Consultant in Anaesthesia and Pain Medicine at University College London Hospital NHS Foundation Trust.
Dr Elizabeth Iveson MBCHB FRCP (UK). Consultant Stroke, Elderly and Neurorehabilitation Physician.
Dr Tim Williams MD PhD MRCPsych. Consultant addiction psychiatrist and clinical director for Avon and Wiltshire Mental Health Trust.
Dr Chloe Sakal MBBS BSc MRCPsych – Clinical Director for Project Twenty21
Twenty21 Study Protocol